Leuprorelin implant - ALZA
Alternative Names: Leuprolide acetate implant; Leuprolide implant; Leuprorelin acetate implant; Leuprorelin implant; Viadur; Viadur™Latest Information Update: 18 Nov 2021
At a glance
- Originator ALZA Corporation; Crescendo Pharmaceuticals
- Developer ALZA Corporation; Bayer; Crescendo Pharmaceuticals
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Prostate cancer